Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Doravirine Dose Optimisation in Pregnancy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dose optimization of doravirine in pregnancy for HIV. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIFELTRO (doravirine)

Snippet

Sponsor: University of Liverpool | Conditions: HIV | Phase 4 | Status: RECRUITING